Contract 75A50122C00076
Mapp Biopharmaceutical, Inc. · Department Of Health And Human Services · September 28, 2022
Mapp Biopharmaceutical, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 28, 2022 for $78.48 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in San Diego, CA. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses cost-plus contract pricing. The most recent modification was on February 20, 2026. If all options are exercised, the contract could reach $299.05 million.
Contract details
- PIID
- 75A50122C00076
- Award type
- Definitive Contract
- Pricing
- Cost Plus Fixed Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- San Diego, CA
- First action
- September 28, 2022
- Latest action
- February 20, 2026
Description
TRANSFER PROPERTY TO HHSO100201600021C.
Modification timeline
-
February 20, 2026Mod P00015 · Supplemental Agreement For Work Within Scope$110.88M
-
August 25, 2025Mod P00014 · Other Administrative ActionRECEIVE PROPERTY TRANSFER.$110.88M
-
July 7, 2025Mod P00013 · Other Administrative ActionUPDATE COR TO SAIMA ZAMAN AND ALT-COR TO CAROL DIAZ-DIAZ.$110.88M
-
September 24, 2024Mod P00006 · Supplemental Agreement For Work Within ScopeTHIS MOD TRANSFERS GFP BETWEEN CONTRACTS.$110.88M
-
September 28, 2022Base awardTHIS COST-PLUS-FIXED-FEE CONTRACT WITH MAPP BIOPHARMACEUTICAL, INC. (MAPP OR CONTRACTOR) IS FOR THE DEVELOPMENT OF MAPP?S THERAPEUTIC INTERVENTION MBP091, AS AN IMMUNOTHERAPY FOR THE TREATMENT OF MARB…$110.88M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50122C00076?
Contract 75A50122C00076 is a federal contract awarded to Mapp Biopharmaceutical, Inc. by Department Of Health And Human Services on September 28, 2022 for $78.48 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 4 times since the base award.
Who won contract 75A50122C00076?
Mapp Biopharmaceutical, Inc. won contract 75A50122C00076 from Department Of Health And Human Services.
How much is contract 75A50122C00076 worth?
Contract 75A50122C00076 has obligated $78.48 million to date, with a total potential value of $299.05 million if all options are exercised.